Paw Jensen

1.2k total citations
47 papers, 786 citations indexed

About

Paw Jensen is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Paw Jensen has authored 47 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pathology and Forensic Medicine, 15 papers in Oncology and 10 papers in Genetics. Recurrent topics in Paw Jensen's work include Lymphoma Diagnosis and Treatment (20 papers), Chronic Lymphocytic Leukemia Research (9 papers) and CNS Lymphoma Diagnosis and Treatment (7 papers). Paw Jensen is often cited by papers focused on Lymphoma Diagnosis and Treatment (20 papers), Chronic Lymphocytic Leukemia Research (9 papers) and CNS Lymphoma Diagnosis and Treatment (7 papers). Paw Jensen collaborates with scholars based in Denmark, Sweden and United States. Paw Jensen's co-authors include Peter de Nully Brown, Michael Pedersen, Karen Dybkær, Francesco d’Amore, P. E. Ochsner, Imke Lang, Niels Ejskjær, Jakob Madsen, R. Schenk and Gottfried Buchhorn and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Paw Jensen

44 papers receiving 772 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paw Jensen Denmark 15 322 299 155 147 94 47 786
Emilian Snarski Poland 14 198 0.6× 127 0.4× 119 0.8× 251 1.7× 75 0.8× 42 806
Won Sik Lee South Korea 17 234 0.7× 328 1.1× 232 1.5× 96 0.7× 88 0.9× 119 1.0k
R. Russell Jones United Kingdom 22 536 1.7× 199 0.7× 104 0.7× 142 1.0× 79 0.8× 66 1.4k
Özay Özkaya Türkiye 17 83 0.3× 187 0.6× 40 0.3× 398 2.7× 88 0.9× 124 1.1k
Henrik Skjødt Denmark 20 118 0.4× 153 0.5× 79 0.5× 133 0.9× 31 0.3× 34 1.2k
Kris M. Mahadeo United States 20 73 0.2× 461 1.5× 210 1.4× 94 0.6× 191 2.0× 113 1.2k
Gülfiliz Gönlüşen Türkiye 16 93 0.3× 191 0.6× 37 0.2× 171 1.2× 291 3.1× 68 885
Su Gülsün Berrak Türkiye 12 69 0.2× 78 0.3× 79 0.5× 81 0.6× 150 1.6× 35 554
Debdatta Basu India 14 56 0.2× 91 0.3× 109 0.7× 127 0.9× 56 0.6× 97 563
Hyeon Gyu Yi South Korea 14 76 0.2× 255 0.9× 89 0.6× 76 0.5× 176 1.9× 51 616

Countries citing papers authored by Paw Jensen

Since Specialization
Citations

This map shows the geographic impact of Paw Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paw Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paw Jensen more than expected).

Fields of papers citing papers by Paw Jensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paw Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paw Jensen. The network helps show where Paw Jensen may publish in the future.

Co-authorship network of co-authors of Paw Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of Paw Jensen. A scholar is included among the top collaborators of Paw Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paw Jensen. Paw Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jensen, Paw, Peter de Nully Brown, Pär Josefsson, et al.. (2025). Impact of Trial Eligibility Criteria on Outcomes of 1183 Patients With Follicular Lymphoma Treated in the Real‐World Setting. European Journal Of Haematology. 114(5). 832–839.
2.
Poulsen, Laurids Østergaard, Carsten Utoft Niemann, Paw Jensen, et al.. (2025). Machine Learning for Prediction of High‐Risk Hospitalizations in Lymphoma Patients: A Danish Population‐Based Study. European Journal Of Haematology. 115(5). 443–453. 1 indexed citations
3.
Brown, Peter de Nully, Matthew J. Maurer, Arushi Khurana, et al.. (2024). The impact of trial inclusion criteria on outcomes in DLBCL patients treated with R-CHOP in the first line: a Danish nationwide study. Leukemia & lymphoma. 65(14). 2173–2181. 2 indexed citations
4.
Gormsen, Lars Christian, Lasse Hjort Jakobsen, Toby A. Eyre, et al.. (2023). The impact of CHOP versus bendamustine on bone mineral density in patients with indolent lymphoma enrolled in the GALLIUM study. British Journal of Haematology. 204(4). 1271–1278. 2 indexed citations
5.
Severinsen, Marianne Tang, et al.. (2023). An Aggressive Course of Transformed Splenic Diffuse Red Pulp Small B-Cell Lymphoma With Novel Somatic Loss-of-Function Mutation in RB1. Journal of Hematology. 12(3). 118–122. 1 indexed citations
6.
Jensen, Paw, Lasse Hjort Jakobsen, Martin Bøgsted, et al.. (2022). A randomized trial of alendronate as prophylaxis against loss in bone mineral density following lymphoma treatment. Blood Advances. 6(8). 2549–2556. 7 indexed citations
7.
Eyre, Toby A., Paw Jensen, Stephen Booth, & Tarec Christoffer El‐Galaly. (2022). Bone health and glucocorticoid‐containing lymphoma therapy — a review of risk factors and preventative measures. British Journal of Haematology. 198(3). 431–442. 7 indexed citations
8.
Schönherz, Anna A., Julie Støve Bødker, Alexander Schmitz, et al.. (2020). Normal myeloid progenitor cell subset-associated gene signatures for acute myeloid leukaemia subtyping with prognostic impact. PLoS ONE. 15(4). e0229593–e0229593. 3 indexed citations
9.
Bødker, Julie Støve, Mads Sønderkær, Alexander Schmitz, et al.. (2020). Development of a Precision Medicine Workflow in Hematological Cancers, Aalborg University Hospital, Denmark. Cancers. 12(2). 312–312. 8 indexed citations
10.
Ejskjær, Niels, et al.. (2019). Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review. Cancer Chemotherapy and Pharmacology. 84(3). 471–485. 87 indexed citations
11.
Arboe, Bente, Pär Josefsson, Christian Poulsen, et al.. (2016). Rituximab Maintenance after First Line Immunochemotherapy Improves Overall Survival in Patients with Follicular Lymphoma. Blood. 128(22). 1781–1781. 2 indexed citations
12.
13.
14.
El‐Galaly, Tarec Christoffer, Karen Dybkær, Martin Bøgsted, et al.. (2015). The application of human phase 0 microdosing trials: A systematic review and perspectives. Leukemia & lymphoma. 57(6). 1281–1290. 5 indexed citations
15.
Madsen, Charlotte Bernhard, Martin Bjerregård Pedersen, Knud Bendix, et al.. (2014). Outcome determinants for transformed indolent lymphomas treated with or without autologous stem-cell transplantation. Annals of Oncology. 26(2). 393–399. 32 indexed citations
16.
El‐Galaly, Tarec Christoffer, Karen Juul Mylam, Maria Rossing, et al.. (2013). Patient-reported symptoms are still the single most important factor for detecting lymphoma relapse. Hematological Oncology. 31. 1 indexed citations
17.
Gregersen, Henrik, et al.. (2006). Fracture risk in patients with monoclonal gammopathy of undetermined significance. British Journal of Haematology. 135(1). 62–67. 36 indexed citations
18.
Bousher, Andrew, et al.. (1999). Establishing a method for assessing and ranking restoration strategies for radioactively contaminated sites and their immediate surroundings. Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU). 3 indexed citations
19.
Jensen, Paw, et al.. (1998). Transitional-cell carcinoma in a 25-year-old renal allograft. Nephrology Dialysis Transplantation. 13(12). 3240–3241. 11 indexed citations
20.
Riely, Caroline A., Edward Cotlier, Paw Jensen, & Gerald Klatskin. (1978). New keys to the differential diagnosis of familial intrahepatic cholestasis. Gastroenterology. 75(5). 983. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emilian Snarski Breakdown of academic impact, for papers by Won Sik Lee Breakdown of academic impact, for papers by R. Russell Jones Breakdown of academic impact, for papers by Özay Özkaya Breakdown of academic impact, for papers by Henrik Skjødt Breakdown of academic impact, for papers by Kris M. Mahadeo Breakdown of academic impact, for papers by Gülfiliz Gönlüşen Breakdown of academic impact, for papers by Su Gülsün Berrak Breakdown of academic impact, for papers by Debdatta Basu Breakdown of academic impact, for papers by Hyeon Gyu Yi
Rankless by CCL
2026